NCT03370068 (ICSI) is a NA clinical trial of ICSI in Infertility, Female, sponsored by Dr. Tal Miller-Elkan.

Who is sponsoring NCT03370068?

NCT03370068 is sponsored by Dr. Tal Miller-Elkan.

What drugs are being tested in NCT03370068?

Interventions in NCT03370068: ICSI, Conventional IVF.

What condition does NCT03370068 study?

NCT03370068 studies Infertility, Female.

Is NCT03370068 still recruiting?

NCT03370068 is currently completed. Last updated 28 July 2020.

Last reviewed 2020-07-28 · How we verify

NCT03370068: ICSI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Role of ICSI in Non-male Factor Infertility in Advanced Maternal Age

Completed NA Last updated 28 July 2020

What this trial tests

NA trial testing ICSI in Infertility, Female in 69 participants. Completed in 1 July 2020.

Timeline

1 January 2018

Primary endpoint
1 July 2020

1 July 2020

Quick facts

Lead sponsor	Dr. Tal Miller-Elkan
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	69
Start date	1 January 2018
Primary completion	1 July 2020
Estimated completion	1 July 2020
Sites	1 location across Israel

Drugs / interventions tested

ICSI
Conventional IVF

Conditions studied

Infertility, Female — all drugs for Infertility, Female →

Sponsor

Dr. Tal Miller-Elkan

Who can join

Adults 39 to 44, female only, with Infertility, Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The use of Intracytoplasmic sperm injection (ICSI) has increased in the last decades regardless of the cause of infertility. Despite the increased use there is no clear evidence that ICIS is more effective than conventional in vitro fertilization (IVF) for non-male factor infertility. The investigators therefore aim to perform a prospective randomized controlled study to compare between ICSI and conventional IVF in women between 39 to 44 years of age with non-male factor infertility.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The role of ICSI vs. conventional IVF for patients with advanced maternal age-a randomized controlled trial.
Haas J, Miller TE, Nahum R, Aizer A, et al · · 2021 · cited 22× · PMID 33118102 · DOI 10.1007/s10815-020-01990-5

Verify or expand the search:

Other trials of ICSI

Trials testing the same drug.

NCT07294027 — ICSI Versus Conventional IVF in Couples With Unexplained Infertility · NA · not yet recruiting
NCT06539585 — Scanning the Meiotic Spindle in Assisted Reproductive Techniques to Assess Oocyte Quality · NA · active not recruiting
NCT05837325 — Is the AMH Intrafollicular Level a Predictor of the Ploidy Status of the Blastocyst? · recruiting
NCT05548101 — Prospective, Randomized Trial Comparing ICSI to Insemination for Non-Male Factor Patients Undergoing PGT-A · NA · unknown
NCT04128904 — In Vitro Fertilisation Versus Intracytoplasmic Sperm Injection in Patients Without Severe Male Factor Infertility · NA · active not recruiting

Other recruiting trials for Infertility, Female

Currently open trials in the same condition.

NCT06771401 — Identification of Biomarkers in Cervical Mucus · NA · recruiting
NCT06984081 — CAPA In-vitro Oocyte Maturation · NA · recruiting
NCT07308561 — The Relationship Between Quality of Life, Anxiety Levels, and Attitudes Toward Artificial Intelligence Among Women Under · recruiting
NCT07175571 — SISTER: Sibling Oocyte Insemination With Frozen Sperm From Third Party Donors: Evaluation of Reproductive Techniques · NA · recruiting
NCT06193135 — Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitar · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03370068 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dr. Tal Miller-Elkan
Last refreshed: 28 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03370068.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing